As of 2025-04-18, the Relative Valuation of 4D Molecular Therapeutics Inc (FDMT) is (116.39) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.06 USD, the upside of 4D Molecular Therapeutics Inc based on Relative Valuation is -3903.8%.
The range of the Relative Valuation is (95.55) - (114.73) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.5x - 40.6x | 36.5x |
| Forward P/E multiples | 23.5x - 33.0x | 30.5x |
| Fair Price | (95.55) - (114.73) | (116.39) |
| Upside | -3222.5% - -3849.2% | -3903.8% |
| Date | P/E |
| 2025-04-15 | -0.89 |
| 2025-04-14 | -0.80 |
| 2025-04-11 | -0.76 |
| 2025-04-10 | -0.75 |
| 2025-04-09 | -0.79 |
| 2025-04-08 | -0.72 |
| 2025-04-07 | -0.76 |
| 2025-04-04 | -0.80 |
| 2025-04-03 | -0.83 |
| 2025-04-02 | -0.94 |
| 2025-04-01 | -0.86 |
| 2025-03-31 | -0.93 |
| 2025-03-28 | -1.04 |
| 2025-03-27 | -1.02 |
| 2025-03-26 | -1.04 |
| 2025-03-25 | -1.06 |
| 2025-03-24 | -1.13 |
| 2025-03-21 | -1.13 |
| 2025-03-20 | -1.08 |
| 2025-03-19 | -1.09 |
| 2025-03-18 | -1.10 |
| 2025-03-17 | -1.20 |
| 2025-03-14 | -1.18 |
| 2025-03-13 | -1.23 |
| 2025-03-12 | -1.22 |
| 2025-03-11 | -1.18 |
| 2025-03-10 | -1.12 |
| 2025-03-07 | -1.17 |
| 2025-03-06 | -1.19 |
| 2025-03-05 | -1.20 |
| 2025-03-04 | -1.14 |
| 2025-03-03 | -1.19 |
| 2025-02-28 | -1.30 |
| 2025-02-27 | -1.29 |
| 2025-02-26 | -1.38 |
| 2025-02-25 | -1.31 |
| 2025-02-24 | -1.30 |
| 2025-02-21 | -1.34 |
| 2025-02-20 | -1.34 |
| 2025-02-19 | -1.36 |
| 2025-02-18 | -1.40 |
| 2025-02-14 | -1.40 |
| 2025-02-13 | -1.36 |
| 2025-02-12 | -1.31 |
| 2025-02-11 | -1.32 |
| 2025-02-10 | -1.53 |
| 2025-02-07 | -1.72 |
| 2025-02-06 | -1.88 |
| 2025-02-05 | -1.77 |
| 2025-02-04 | -1.70 |